Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kerkhoff, Andrew D ^a,b,c   Wood, Robin ^b   Vogt, Monica ^b   Lawn, Stephen D ^b,d,e  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; HEMOGLOBIN; LIPOARABINOMANNAN; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GOLD STANDARD; HEMOGLOBIN BLOOD LEVEL; HIV ASSOCIATED TUBERCULOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DEVICE; LIPID ANALYSIS; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL COUNT; NONHUMAN; OPTICAL DENSITY; OUTPATIENT; PROGNOSIS; QUANTITATIVE DIAGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY; SOUTH AFRICA; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; SYMPTOM; TUBERCULOSIS; URINALYSIS; URINE LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; IMMUNOLOGY; MICROBIOLOGY; MIXED INFECTION; RISK FACTOR; URINE; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIAL LOAD; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MALE; PROGNOSIS; RISK FACTORS; TUBERCULOSIS; VIRAL LOAD; YOUNG ADULT;

EID: 84904962770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103285     Document Type: Article

References (35)

1. World Health Organization (2013) Global tuberculosis report 2013. World Health Organization, Geneva, 2013. Accessible at the following URL: http://appswhoint/iris/bitstream/10665/91355/1/9789241564656-engpdf.
2. Lawn SD, Wood R (2011) Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and Diagnosis. J Infect Dis 204: S1159-S1167. doi:10.1093/infdis/jir411
3. Getahun H, Harrington M, O'Brien R, Nunn P (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049. doi:10.1016/S0140-6736(07)60284-0 (Pubitemid 46908825)
4. Dawson R, Masuka P, Edwards DJ, Bateman ED, Bekker L-G, et al. (2010) Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 14: 52-58.
5. Rylance J, Pai M, Lienhardt C, Garner P (2010) Priorities for tuberculosis research: a systematic review. Lancet Infect Dis 10: 886-892. doi:10.1016/S1473-3099(10)70201-2
6. Zumla A, Kim P, Maeurer M, Schito M (2013) Zero deaths from tuberculosis: progress, reality, and hope. Lancet Infect Dis 13: 285-7. doi:10.1016/S1473- 3099(13)70039-2
7. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, et al. (2013) Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13: 349-361. doi:10.1016/S1473-3099(13) 70008-2
8. Lawn SD (2012) Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis 12: 103. doi:10.1186/1471-2334-12-103
9. Lawn SD, Kerkhoff AD, Vogt M, Wood R (2012) Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 12: 201-209. doi:10.1016/S1473-3099(11)70251-1
10. Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, et al. (2012) Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 40: 1211-1220. doi:10.1183/09031936.00201711
11. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker L-G, et al. (2009) Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23: 1875-1880.
12. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, et al. (2009) Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr 52: 145-151. doi:10.1097/QAI.0b013e3181b98430
13. Lawn SD, Kerkhoff AD, Vogt M, Wood R (2012) Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis. AIDS 26: 1635-1643. doi:10.1097/QAD. 0b013e3283553685
14. Gounder CR, Kufa T, Wada NI, Mngomezulu V, Charalambous S, et al. (2011) Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. J Acquir Immune Defic Syndr 58: 219-223. doi:10.1097/QAI.0-b013e31822b75d4
15. Lawn SD, Kerkhoff AD, Vogt M, Wood R (2013) HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays. BMC Med 11: 231. doi:10.1186/1741-7015-11-231
16. Boehme C, Molokova E, Minja F, Geis S, Loscher T, et al. (2005) Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 99: 893-900. doi:10.1016/j.trstmh.2005.04.014 (Pubitemid 41511449)
17. Lawn SD, Myer L, Bekker L-G, Wood R (2006) Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 20: 1605-1612. doi:10.1097/01.aids.0000238406.93249.cd (Pubitemid 44162402)
18. Lawn SD, Myer L, Orrell C, Bekker L-G, Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19: 2141-2148. (Pubitemid 41669003)
19. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, et al. (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 8: e1001067. doi:10.1371/journal.pmed.1001067
20. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, et al. (2012) Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 54: 1071-1079. doi:10.1093/cid/cir1039
21. Lawn SD, Kerkhoff AD, Pahlana P, Vogt M, Wood RR (2012) Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy. Int J Tuberc Lung Dis 16: 1354-1357. doi:10.5588/ijtld.12.0174
22. World Health Organization (2011) Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Mineral Nutrition Information System. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/vmnis/indicators/haemoglobin.pdf. 2011.
23. Kerkhoff AD, Wood R, Vogt M, Lawn SD (2013) Predictive value of anemia for tuberculosis in HIV-infected patients in sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. J Acquir Immune Defic Syndr. doi:10.1097/QAI.0000000000000091
24. Lawn SD, Dheda K, Kerkhoff AD, Peter JG, Dorman S, et al. (2013) Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect Dis 13: 407. doi:10.1186/1471-2334-13-407
25. Talbot E, Munseri P, Teixeira P, Matee M, Bakari M, et al. (2012) Test Characteristics of Urinary Lipoarabinomannan and Predictors of Mortality among Hospitalized HIV-Infected Tuberculosis Suspects in Tanzania. PLoS ONE 7: e32876. doi:10.1371/journal.pone.0032876.t004
26. Shah M, Martinson NA, Chaisson RE, Martin DJ, Variava E, et al. (2010) Quantitative Analysis of a Urine-Based Assay for Detection of Lipoarabinomannan in Patients with Tuberculosis. J Clin Micro 48: 2972-2974. doi:10.1128/JCM. 00363-10
27. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, et al. (1993) The mortality and pathology of HIV infection in a west African city. AIDS 7: 1569-1579. (Pubitemid 24008849)
28. Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, et al. (2000) Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 24: 23-29. (Pubitemid 30447802)
29. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, et al. (2002) Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 6: 55-63. (Pubitemid 34263546)
30. Cohen T, Murray M, Wallengren K, Alvarez GG, Samuel EY, et al. (2010) The Prevalence and Drug Sensitivity of Tuberculosis among Patients Dying in Hospital in KwaZulu-Natal, South Africa: A Postmortem Study. PLoS Med 7: e1000296. doi:10.1371/journal.pmed.1000296.t005
31. Wong EB, Omar T, Setlhako GJ, Osih R, Feldman C, et al. (2012) Causes of Death on Antiretroviral Therapy: A Post-Mortem Study from South Africa. PLoS ONE 7: e47542. doi:10.1371/journal.pone.0047542.t004
32. Lanjewar DN, Duggal R (2001) Pulmonary pathology in patients with AIDS: an autopsy study from Mumbai. HIV Med 2: 266-271. (Pubitemid 33114771)
33. Kerkhoff AD, Wood R, Lowe DM, Vogt M, Lawn SD (2013) Blood neutrophil counts in HIV-infected patients with pulmonary tuberculosis: association with sputum mycobacterial load. PLoS ONE 8: e67956. doi:10.1371/journal.pone.0067956
34. Lowe DM, Bandara AK, Packe GE, Barker RD, Wilkinson RJ, et al. (2013) Neutrophilia independently predicts death in tuberculosis. Eur Resp J 42: 1752-1757. doi:10.1183/09031936.00140913
35. Lawn SD, Kerkhoff AD, Vogt M, Wood RR (2013) Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. Int J Tuberc Lung Dis 17: 636-643. doi:10.5588/ijtld.12.0811